Robert Malmstrom, PharmD

Article

Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network

Author:: Robert Malmstrom, PharmD

Publish date: May 8, 2026

Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation.

Article

Impact of Multisite Patient Education on Pharmacotherapy for Veterans With Alcohol Use Disorder

Author:: Robert Malmstrom, PharmD

Publish date: May 19, 2025

Excessive alcohol use is one of the leading preventable causes of death in the United States, responsible for about 178,000 deaths annually and an ...